Dintec

Myrtecaine lauryl sulfate ............................................................................................................. 2.50 mg

(Corresponding amount of myrtecaine base .................................................................................. 1.25 mg)

Basic aluminum aminoacetate ................................................................................................ 250.00 mg

Galactane sulfate .................................................................................................................... 200.00 mg

For 1 tablet

1 tablet contains 0.05 g of aluminum, 0.6 g of sucrose, 0.35 g of lactose and 2 mg of glycyrrhizin and yellow orange S (E 110).

For a complete list of excipients,see section 6.1.

Symptomatic treatment of painful manifestations during oesophageal ailments.

Symptomatic treatment of painful manifestations during oesophageal ailments.

This medicine should not be used in case of a history of allergy to any of the constituents.

For renal impairment and chronic dialysis patients, consider the aluminium content (0.05 g per tablet) (risk of encephalopathy).

The attention of athletes will be drawn to the fact that this specialty contains an active substance that can induce a positive reaction of the tests performed during anti-doping controls.

In case of diabetes or hypoglucidic diet, take into account the sucrose and lactose content (0.6 g sucrose and 0.35 g lactose per tablet).

This drug contains lactose and sucrose. Its use is not recommended in patients with intolerance to fructose, galactose, Lapp lactase deficiency or glucose-galactose malabsorption syndrome or sucrase/isomaltase deficiency (rare hereditary diseases).

This medicine contains an azo colouring agent (orange yellow (E110)) and may cause allergic reactions.

* Related to aluminum: during long-term treatment or overdose, risk of phosphorus depletion, constipation.

* Related to myrtecaine: possibility of allergy.

No information provided.

Not informed.

Not applicable.